
You can purchase shares of NYKODE THERAPEUTICS AS by NYKODE THERAPEUTICS AS (OTCPK:VACBF) through any online brokerage.
There are no as such competitors for NYKODE THERAPEUTICS AS by NYKODE THERAPEUTICS AS.
There is no analysis for NYKODE THERAPEUTICS AS by NYKODE THERAPEUTICS AS to provide a consensus price target.
The stock price for NYKODE THERAPEUTICS AS by NYKODE THERAPEUTICS AS (OTCPK: VACBF) is $0.2974 last updated October 23, 2026 at 9:30 AM EDT.
There are no upcoming dividends for NYKODE THERAPEUTICS AS by NYKODE THERAPEUTICS AS.
NYKODE THERAPEUTICS AS by NYKODE THERAPEUTICS AS does not have any upcoming earnings scheduled.
There is no upcoming split for NYKODE THERAPEUTICS AS by NYKODE THERAPEUTICS AS.
NYKODE THERAPEUTICS AS by NYKODE THERAPEUTICS AS is in the Health Care sector and Biotechnology industry. They are listed on the OTCPK.
Nykode Therapeutics AS is a clinical-stage biopharmaceutical company focused on the discovery and development of novel immunotherapies. The company is developing individualized cancer neoantigen vaccines and is using the Vaccibody technology to...